Rani Therapeutics
A company developing biotherapeutics for the delivery of large drug molecules, peptides, proteins and antibodies
All edits
March 7, 2018
On February 7, 2018 Rani Therapeutics completed a venture funding round with $53 million in funding from Shire (lead investor), GeneScience Pharmaceuticals (lead investor), Cathey Venture (lead investor), Bossa Ventures (lead investor), Virtus Inspire Ventures, Ping An Ventures, Google Ventures, and AstraZeneca.
September 9, 2017
On September 9, 2017 Rani Therapeutics completed their series D funding round with $39 million in funding from Google Ventures (lead investor), Novartis, and AstraZeneca.
May 26, 2015
On May 26, 2015 Rani Therapeutics completed their series C funding round with $37.5 million in funding from Western Life Sciences Venture Fund, VentureHealth, The Stevanato Group, Pinemount Investment, Pacific Venture Opportunity Fund, Novartis, InCube Ventures, Google Ventures, and Crystal Horizon Investments.
July 28, 2013
On July 28, 2013 Rani Therapeutics completed their series B funding round with $9.4 million in funding from Google Ventures (lead investor) and InCube Ventures.
June 13, 2012
On June 13, 2012 Rani Therapeutics completed their series A funding round with $4 million in funding from InCube Ventures.
On June 13, 2012 Rani Therapeutics completed their series A funding round with $4 million in funding from InCube Ventures.
On July 28, 2013 Rani Therapeutics completed their series B funding round with $9.4 million in funding from Google Ventures (lead investor) and InCube Ventures.
On May 26, 2015 Rani Therapeutics completed their series C funding round with $37.5 million in funding from Western Life Sciences Venture Fund, VentureHealth, The Stevanato Group, Pinemount Investment, Pacific Venture Opportunity Fund, Novartis, InCube Ventures, Google Ventures, and Crystal Horizon Investments.
On September 9, 2017 Rani Therapeutics completed their series D funding round with $39 million in funding from Google Ventures (lead investor), Novartis, and AstraZeneca.
On February 7, 2018 Rani Therapeutics completed a venture funding round with $53 million in funding from Shire (lead investor), GeneScience Pharmaceuticals (lead investor), Cathey Venture (lead investor), Bossa Ventures (lead investor), Virtus Inspire Ventures, Ping An Ventures, Google Ventures, and AstraZeneca.
Find more companies like Rani Therapeutics
